Cargando…
Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies
Autores principales: | Vanholder, Raymond, Laecke, Steven Van, Verbeke, Francis, Glorieux, Griet, Biesen, Wim Van |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375242/ https://www.ncbi.nlm.nih.gov/pubmed/30792775 http://dx.doi.org/10.1093/ndtplus/sfm024 |
Ejemplares similares
-
Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease
por: Verbeke, Francis, et al.
Publicado: (2022) -
The prevention of acute kidney injury: an in-depth narrative review Part 1: volume resuscitation and avoidance of drug- and nephrotoxin-induced AKI
por: Lameire, Norbert, et al.
Publicado: (2008) -
The prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury
por: Lameire, Norbert, et al.
Publicado: (2009) -
What is new in uremic toxicity?
por: Vanholder, Raymond, et al.
Publicado: (2008) -
Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)
por: Vanholder, Raymond, et al.
Publicado: (2018)